Proactive Investors - Run By Investors For Investors

Hansen Medical shares burgeon by 50% after FDA green light

Euphoria was investors' reaction to news that Hansen Medical was granted clearance for its Robotic Catheter eKit from U.S. authorities and the company's shares advanced 50%.
Hansen Medical shares burgeon by 50% after FDA green light
Robotic Catheter eKits get FDA clearance
Euphoria was investors' reaction to news that Hansen Medical (NASDAQ:HNSN) was granted clearance for its Robotic Catheter eKit from US authorities and the company's shares advanced 50%.
 
Although widely touted as ripe for clearance, the news that Hansen Medical's Magellan Robotic Catheter eKit had received the nod from the US Food and Drug Administration came as some relief.
 
Shares raced up by as much as 50.6% to US$4.82 earlier, having traded at around US$2 in the last week of January. The price was last seen up 29%, or 92 cents at USD4.12.
 
The eKits allow doctors to control third party microcatheters robotically through current Megellan Robotic Catheter 6Fr architecture. The goal of the kits is to help reduce exposure time to radiation and overall procedure time.
 
View full HNSN profile View Profile

Hansen Medical Timeline

Related Articles

harley street
May 10 2019
Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020
researcher
April 30 2019
We take a look at a company with a unique approach to drug development that may ultimately help big pharma replenish its pipeline
test tubes
May 07 2019
Here we take a closer look at Arix Biosciences PLC (LON:ARIX), a listed venture capital company that doesn’t appear to be receiving the recognition it deserves
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use